I include below a selection of 3 questions put to Mr Peter Copetti in the recent Midas interview; they are taken from a transcript :

James West: Okay. Exactly what is the nature of the breakthrough? What’s so disruptive about it?

Peter Copetti: That’s really the heart and soul of our IP –our Secret Sauce. So we’ve got to be careful here without getting too technical, but basically Geoff Taylor has developed a p-channel in gallium arsenide that is always off, that’s the very first time that’s been done. He’s combined that with PNN HFETs and PNN HBTs which are transistors and finally that is his optical thyristor. All of these are backed by over 40 patents with more pending and that’s the extent at which I want to disclose on an interview like this without NDA.

James West: Okay. So what major industry names would seek to acquire the POET platform or else use it or incorporate it into their developmental process?

Peter Copetti: Well, we’re not building POET to be acquired; we’re building it to stand alone and to be successful on its own. However, the disruptiveness of the inherent nature of the technology is so great that someone most likely will want to control it. I don’t want to get into specific names. That’s about all I’d like to say on that topic for now.

James West: Okay. So that’s what’s going to trigger revenue in 2014, is the actual establishment of a partnership as one of the first industrial partners with POET.

Peter Copetti: Yes, absolutely. Up until this point, the market’s been concentrating on many of our technical milestones and they’re very important. But now, we’re at the stage where we need to verify with not just the institutional, not just with the investment community but also with the industry community that POET is actually real and tangible, and the only way to do that is by doing commercial deals and that’s what we’re working on in earnest.

I make some points and the relevant areas are underlined:

1. He discloses but does not enlarge upon the technology which involves a revolutionary change in the way transistors and thyristors operate (they are the mass of electronic devices printed or etched onto a microprocessor).
2. He states that the technology is so disruptive that it is likely someone (a mega-cap company presumably) will want to control it, though the companies aim is to stand alone.
3. He summarise the strategic steps in its development and indicates that they are at the final stage of commercialisation by persuading the microprocessor industry that this technology exists and can be tested. This process is now being pursued earnestly.

For those attending Dr Taylor's lecture, it may well be that the revolutionary nature of POET will be discussed. This may be the reason this lecture was arranged and, as it is not directly a financial matter, no NR is required for the output is scientific. However, IMO this is the centre of POET's advantage over other microprocessors and is the focus to why this is such a saleable product. Everything else is secondary.

Mr Copetti's background is in finance and management and not technology. Dr Taylor is a or perhaps the world authority on GaAs semiconductors, he will know everything about potential and its true position in the semiconductor universe. Mr Copetti knows, for certain, the current interest of other companies in this technology. These 2 persons are the ones who truly know the potential and far more than we do. Everybody, listen with care tomorrow.

The broadcast to Midas was made by someone who truly knows and understands the current status of POET. This management has always been credible in its previous news releases; it does not pad out its claims in my experience and I have not heard any suggestion of hypebole or misinformation. Around these 2 speakers centres all our hopes on a possibly staggeringly lucrative investment.

David